Dr. Carmine C. Marchioli

Mark Keating, MD, is a medical oncologist specializing in tumors and diseases of the blood. He has a particular expertise in the diagnosis and treatment of gastrointestinal, kidney, bladder, breast, lung, head and neck, and prostate cancers, as well as chronic leukemia, lymphoma, brain tumors, and benign hematologic disorders. Dr. Keating is rated as a Distinguished provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Paget Disease of the Breast, and Non-Hodgkin Lymphoma.

Ibrahim Sbeitan, MD, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center. Dr. Sbeitan received his medical degree from the University of Jordan School of Medicine and completed his residency at Gundersen Medical Foundation in La Crosse, Wisconsin, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Sbeitan is rated as a Distinguished provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Chronic Familial Neutropenia, Familial Colorectal Cancer, Lynch Syndrome, and Colorectal Cancer.

Eric Safyan, MD, is board-certified in Internal Medicine and Medical Oncology. He is a Clinical Assistant Professor of Medicine at the University of Pittsburgh School of Medicine and is the leader of the Telemedicine Clinic at UPMC Hillman Cancer Center at UPMC Altoona. Dr. Safyan received his medical degree from the University of Pittsburgh School of Medicine. He completed his Internal Medicine residency at Wadsworth VA in Los Angeles, California and completed his fellowship in both Hematology and Medical Oncology at Harbor - UCLA Medical Center in Torrance, California. Dr. Safyan is rated as an Advanced provider by MediFind in the treatment of Gastric Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma.